Crossmark

Nanotechnology-enhanced immunotherapies for pancreatic ductal adenocarcinoma: challenges and opportunities

Published Online: 2025-07-08

Authors

Yang, Sheng

Ta, Yen-Nhi Ngoc

Chen, Yunching https://orcid.org/0000-0001-6228-5169
Funding

Funding for this research was provided by:

National Tsing Hua University
License Information

Text and Data Mining valid from 2025-07-08

Version of Record valid from 2025-07-08
More Information

Article History

Accepted: 20 June 2025

First Online: 8 July 2025

Declarations

:

: Not applicable.

: All authors have approved the final version of the manuscript.

: All authors declare no competing interests.

Document is current